Description
Astilbin, isolated from the rhizomes of Astilbe chinensis (Maxim.) Franch. et Sav., is a potential candidate drug for inflammatory bowel disease due to its ability to mediate the regulatory functions of dendritic cells (DCs).
IUPAC Name: (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2,3-dihydrochromen-4-one
InChI: InChI=1S/C21H22O11/c1-7-15(26)17(28)18(29)21(30-7)32-20-16(27)14-12(25)5-9(22)6-13(14)31-19(20)8-2-3-10(23)11(24)4-8/h2-7,15,17-26,28-29H,1H3/t7-,15-,17+,18+,19+,20-,21-/m0/s1
InChIKey: ZROGCCBNZBKLEL-MPRHSVQHSA-N
SMILES: C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](OC3=CC(=CC(=C3C2=O)O)O)C4=CC(=C(C=C4)O)O)O)O)O
Synonyms: Astilbin; 29838-67-3; Taxifolin 3-O-rhamnoside; Isoastilbin; Dihydroquercitrin; CHEBI:38200; Dihydroquercetin 3-rhamnoside; (2R-cis)-isomer of astilbin; …
Botanical Source: Smilax Glabra